National Health Investors (NYSE:NHI) Releases FY19 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY19 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $5.47-5.50 for the period, compared to the Thomson Reuters consensus estimate of $5.47.

NHI stock traded down $0.48 during trading on Thursday, reaching $80.42. 91,665 shares of the company’s stock were exchanged, compared to its average volume of 170,395. The company has a quick ratio of 14.42, a current ratio of 14.42 and a debt-to-equity ratio of 1.04. National Health Investors has a 1-year low of $73.35 and a 1-year high of $86.54. The company’s fifty day moving average price is $83.63 and its 200-day moving average price is $80.54. The firm has a market cap of $3.67 billion, a PE ratio of 14.67, a P/E/G ratio of 3.86 and a beta of 0.27.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported $0.92 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.37 by ($0.45). National Health Investors had a return on equity of 11.00% and a net margin of 50.71%. The business had revenue of $78.10 million for the quarter, compared to analyst estimates of $77.64 million. During the same quarter last year, the firm posted $1.38 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. As a group, sell-side analysts expect that National Health Investors will post 5.49 earnings per share for the current fiscal year.

A number of research analysts have issued reports on NHI shares. ValuEngine upgraded National Health Investors from a sell rating to a hold rating in a research report on Friday, October 25th. Zacks Investment Research upgraded National Health Investors from a sell rating to a hold rating in a report on Friday, November 1st. Two investment analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. The stock has a consensus rating of Hold and a consensus price target of $79.60.

In other news, Director James R. Jobe sold 900 shares of the company’s stock in a transaction on Tuesday, September 24th. The stock was sold at an average price of $83.23, for a total value of $74,907.00. Following the completion of the sale, the director now owns 12,052 shares in the company, valued at $1,003,087.96. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 5.11% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: How do CD ladders protect against rising interest rates?

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.